|
1
|
Esteller M: Non-coding RNAs in human
disease. Nat Rev Genet. 12:861–874. 2011. View Article : Google Scholar
|
|
2
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar
|
|
3
|
Crawford JR, MacDonald TJ and Packer RJ:
Medulloblastoma in childhood: new biological advances. Lancet
Neurol. 6:1073–1085. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zeltzer PM, Boyett JM, Finlay JL, et al:
Metastasis stage, adjuvant treatment, and residual tumor are
prognostic factors for medulloblastoma in children: conclusions
from the Children’s Cancer Group 921 randomized phase III study. J
Clin Oncol. 17:832–845. 1999.PubMed/NCBI
|
|
5
|
Doyonnas R, Yi-Hsin Chan J, Butler LH, et
al: CD164 monoclonal antibodies that block hemopoietic progenitor
cell adhesion and proliferation interact with the first mucin
domain of the CD164 receptor. J Immunol. 165:840–851. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tang J, Zhang L, She X, et al: Inhibiting
CD164 expression in colon cancer cell line HCT116 leads to reduced
cancer cell proliferation, mobility, and metastasis in vitro and in
vivo. Cancer Invest. 30:380–389. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Havens AM, Jung Y, Sun YX, et al: The role
of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer
metastasis. BMC Cancer. 6:1952006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Adamson DC, Shi Q, Wortham M, et al: OTX2
is critical for the maintenance and progression of Shh-independent
medulloblastomas. Cancer Res. 70:181–191. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Luo XG, Zou JN, Wang SZ, Zhang TC and Xi
T: Novobiocin decreases SMYD3 expression and inhibits the migration
of MDA-MB-231 human breast cancer cells. IUBMB Life. 62:194–199.
2010.PubMed/NCBI
|
|
10
|
Frasor J, Danes JM, Komm B, Chang KC,
Lyttle CR and Katzenellenbogen BS: Profiling of estrogen up- and
down-regulated gene expression in human breast cancer cells:
insights into gene networks and pathways underlying estrogenic
control of proliferation and cell phenotype. Endocrinology.
144:4562–4574. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sethupathy P, Megraw M and Hatzigeorgiou
AG: A guide through present computational approaches for the
identification of mammalian microRNA targets. Nat Methods.
3:881–886. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Venkataraman S, Alimova I, Fan R, et al:
MicroRNA 128a increases intracellular ROS level by targeting Bmi-1
and inhibits medulloblastoma cancer cell growth by promoting
senescence. PLoS One. 5:e107482010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Weeraratne SD, Amani V, Teider N, et al:
Pleiotropic effects of miR-183~96~182 converge to regulate cell
survival, proliferation and migration in medulloblastoma. Acta
Neuropathol. 123:539–552. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Garzia L1, Andolfo I, Cusanelli E, et al:
MicroRNA-199b-5p impairs cancer stem cells through negative
regulation of HES1 in medulloblastoma. PLoS One. 4:e49982009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bai AH, Milde T, Remke M, Rolli CG,
Hielscher T, Cho YJ, Kool M, Northcott PA, Jugold M, Bazhin AV,
Eichmüller SB, Kulozik AE, Pscherer A, Benner A, Taylor MD, Pomeroy
SL, Kemkemer R, Witt O, Korshunov A, Lichter P and Pfister SM:
MicroRNA-182 promotes leptomeningeal spread of non-sonic
hedgehog-medulloblastoma. Acta Neuropathol. 123:529–538. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Venkataraman S, Birks DK, Balakrishnan I,
Alimova I, Harris PS, Patel PR, Handler MH, Dubuc A, Taylor MD,
Foreman NK and Vibhakar R: MicroRNA 218 acts as a tumor suppressor
by targeting multiple cancer phenotype-associated genes in
medulloblastoma. J Biol Chem. 288:1918–1928. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Grunder E, D’Ambrosio R, Fiaschetti G,
Abela L, Arcaro A, Zuzak T, Ohgaki H, Lv SQ, Shalaby T and Grotzer
M: MicroRNA-21 suppression impedes medulloblastoma cell migration.
Eur J Cancer. 47:2479–2490. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li KK, Pang JC, Lau KM, Zhou L, Mao Y,
Wang Y, Poon WS and Ng HK: MiR-383 is downregulated in
medulloblastoma and targets peroxiredoxin 3 (PRDX3). Brain Pathol.
23:413–425. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li KK, Pang JC, Ching AK, Wong CK, Kong X,
Wang Y, Zhou L, Chen Z and Ng HK: miR-124 is frequently
down-regulated in medulloblastoma and is a negative regulator of
SLC16A1. Hum Pathol. 40:1234–1243. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dugas JC, Cuellar TL, Scholze A, Ason B,
Ibrahim A, Emery B, Zamanian JL, Foo LC, McManus MT and Barres BA:
Dicer1 and miR-219 are required for normal oligodendrocyte
differentiation and myelination. Neuron. 65:597–611. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Huang N, Lin J, Ruan J, Su N, Qing R, Liu
F, He B, Lv C, Zheng D and Luo R: MiR-219-5p inhibits
hepatocellular carcinoma cell proliferation by targeting
glypican-3. FEBS Lett. 586:884–891. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ferretti E, De Smaele E, Po A, Di
Marcotullio L, Tosi E, Espinola MS, Di Rocco C, Riccardi R,
Giangaspero F, Farcomeni A, Nofroni I, Laneve P, Gioia U,
Caffarelli E, Bozzoni I, Screpanti I and Gulino A: MicroRNA
profiling in human MB. Int J Cancer. 124:568–577. 2009. View Article : Google Scholar
|
